<DOC>
	<DOCNO>NCT00455000</DOCNO>
	<brief_summary>The purpose study determine whether single IV dose PF-04360365 safe well tolerate Adults Mild Moderate Alzheimer 's disease .</brief_summary>
	<brief_title>A Phase I , Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Male Females nonchildbearing potential , age 5085 Diagnosis probable Alzheimer 's disease , consistent criterion : 1 ) National Institute Neurological Communicable Disease Stroke Alzheimer 's Disease Related Disorders Association ( NINCDSADRDA ) ; 2 ) Diagnostic Statistical Manual Mental Disorders ( DSM IV ) Minimental status exam score 1626 inclusive RosenModified Hachinski Ischemia Score &lt; = 4 Diagnosis history dementia neurodegenerative disorder Diagnosis history clinically significant cerebrovascular disease Specific find magnetic resonance imaging ( MRI ) : cortical infarct , micro hemorrhage , multiple white matter lacunes , extensive white matter abnormality History autoimmune disorder History allergic anaphylactic reaction</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>